UNCY Earnings Date: Nov 11, 2026 (Estimated) — Unicycive Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is UNCY's next earnings date?
Unicycive Therapeutics, Inc. (UNCY) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.33 on revenue of $902,778.
How did UNCY do in its last earnings report?
In its most recent report on Aug 12, 2026 (Q2 2026), Unicycive Therapeutics, Inc. posted EPS of -$0.06 versus the -$0.47 estimate, a beat of 81.8%. Revenue was $0 against a $22.2M estimate. The stock's 1-day post-earnings move was +7.8%.
How much does UNCY stock move after earnings?
UNCY beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 7.8% (up or down) in the day after earnings.
About Unicycive Therapeutics, Inc.
Unicycive Therapeutics, Inc. is a U.S.-based biotechnology company dedicated to the creation of innovative treatments for kidney diseases. Its development pipeline includes Renazorb, a therapy for hyperphosphatemia in chronic kidney disease patients, and UNI 494, which is being developed to treat acute kidney injury. Founded in 2016, the firm is headquartered in Los Altos, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | Q2 2026 | -0.47 | -0.06 | +81.82% | $0 | ✅ Beat | +7.80% | +12.60% | +6.20% |
| 2026-05-12 | Q1 2026 | -0.49 | -0.54 | -10.20% | $0 | ❌ Miss | +2.77% | +2.52% | -3.27% |
| 2026-03-30 | Q4 2025 | -0.46 | -0.82 | -78.26% | $0 | ❌ Miss | -4.38% | +3.60% | +12.21% |
| 2025-11-12 | Q3 2025 | -0.55 | -0.46 | +16.36% | $0 | ✅ Beat | +7.31% | +23.59% | +33.82% |
| 2025-03-31 | Q4 2024 | -0.07 | -0.26 | -271.43% | $0 | ❌ Miss | -5.03% | -19.85% | +13.34% |
| 2024-11-13 | Q3 2024 | -0.15 | -0.05 | +66.67% | $0 | ✅ Beat | -1.30% | +0.12% | +52.77% |
| 2024-08-14 | Q2 2024 | -0.19 | -0.15 | +21.05% | $0 | ✅ Beat | +34.03% | +66.95% | +61.02% |
| 2024-05-13 | Q1 2024 | -0.15 | -0.61 | -306.67% | $675,000 | ❌ Miss | +0.00% | -2.75% | -39.41% |
Showing last 8 quarters.